SC-99

A novel selective STAT3 inhibitor that inhibits JAK2-STAT3 activation but has no effects on other transcription factors such as NF-κB, and kinases such as AKT, ERK, and c-Src; inhibits STAT3 phosphorylation, dimerization and nuclear translocation, downregulates STAT3-modulated gene expression and induces MM cell apoptosis; delays tumor growth in MM xenograft models (30mg/kg); orally active.

References 1. Zhang Z, et al. Oncotarget. 2016 Feb 23;7(8):9296-308. 2. Xu Z, et al. Acta Pharmacol Sin. 2017 May;38(5):651-659. View Related Products by Target STAT